![The voice of community pharmacy |Pharamcy Digital Magazine September Edition|Latest Pharmacy News by pharmacybiz - Issuu The voice of community pharmacy |Pharamcy Digital Magazine September Edition|Latest Pharmacy News by pharmacybiz - Issuu](https://assets.isu.pub/document-structure/210922103227-b323b6d5e1359a9aedecbfe75b5d4777/v1/065d8010293a651f57f05fa719ff01ec.jpeg)
The voice of community pharmacy |Pharamcy Digital Magazine September Edition|Latest Pharmacy News by pharmacybiz - Issuu
Advances in Nanomaterial-Based Platforms to Combat COVID-19: Diagnostics, Preventions, Therapeutics, and Vaccine Developments | ACS Applied Bio Materials
![PDF) Clinical characteristics and outcomes of critically ill COVID-19 patients in Tokyo: a single-center observational study from the first wave PDF) Clinical characteristics and outcomes of critically ill COVID-19 patients in Tokyo: a single-center observational study from the first wave](https://i1.rgstatic.net/publication/349170913_Clinical_characteristics_and_outcomes_of_critically_ill_COVID-19_patients_in_Tokyo_a_single-center_observational_study_from_the_first_wave/links/6024868c92851c4ed563179b/largepreview.png)
PDF) Clinical characteristics and outcomes of critically ill COVID-19 patients in Tokyo: a single-center observational study from the first wave
DCGI supports Restricted Use of Anti-viral Drug Favipiravir for Coronavirus Patients - Microbioz India
![DCGI supports Restricted Use of Anti-viral Drug Favipiravir for Coronavirus Patients - Microbioz India DCGI supports Restricted Use of Anti-viral Drug Favipiravir for Coronavirus Patients - Microbioz India](https://sp-ao.shortpixel.ai/client/to_webp,q_glossy,ret_img/https://microbiozindia.com/wp-content/uploads/2020/05/iStock-1209372926-2-1251840297-1590053218-1-651874279-1590315642.jpg)
DCGI supports Restricted Use of Anti-viral Drug Favipiravir for Coronavirus Patients - Microbioz India
![PDF) A Randomized, Open‐label, Controlled Clinical Trial of Azvudine Tablets in the Treatment of Mild and Common COVID‐19, A Pilot Study PDF) A Randomized, Open‐label, Controlled Clinical Trial of Azvudine Tablets in the Treatment of Mild and Common COVID‐19, A Pilot Study](https://i1.rgstatic.net/publication/342932715_A_Randomized_Open-label_Controlled_Clinical_Trial_of_Azvudine_Tablets_in_the_Treatment_of_Mild_and_Common_COVID-19_A_Pilot_Study/links/5f0e5ea8a6fdcc3ed7080e17/largepreview.png)